🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

207 results for “Smith” Clear

  1. Amoxicillin/clavulanate

    GlaxoSmithKline

    Focal Infection, Dental

    approved small molecule completed

    1 trial

  2. Arexvy powder and suspension for suspension for injection Respiratory Syncytial Virus (RSV) vaccine (recombinant, adjuvanted)

    GlaxoSmithKline

    Respiratory Syncytial Virus Infections

    approved small molecule active

    1 trial

  3. Avamys aqueous nasal spray 110mcg

    GlaxoSmithKline

    Rhinitis, Allergic, Perennial

    approved small molecule completed

    1 trial

  4. Benlysta 200 mg solution for injection in pre-filled pen.

    GlaxoSmithKline

    Systemic Lupus Erythematosus

    approved small molecule active

    1 trial

  5. Dutasteride plus tamsulosin

    GlaxoSmithKline

    Prostatic Hyperplasia

    approved small molecule completed

    1 trial

  6. Engerix™ -B

    GlaxoSmithKline

    Hepatitis B

    approved mab completed

    1 trial

  7. IODEX® balm

    GlaxoSmithKline

    Pain

    approved small molecule completed

    1 trial

  8. Infanrix hexa

    GlaxoSmithKline

    Acellular Pertussis

    approved mab completed

    1 trial

  9. Nucala 100 mg solution for injection in pre-filled pen, Nucala 100 mg solution for injection in pre-filled syringe, Nucala 100 mg solution for injection in pre-filled syringe, Nucala 100 mg solution for injection in pre-filled pen, Nucala 100 mg solution for injection in pre-filled pen, Nucala 100 mg solution for injection in pre-filled syringe

    GlaxoSmithKline

    severe asthma

    approved small molecule active

    1 trial

  10. ROP

    GlaxoSmithKline

    Parkinson Disease

    approved small molecule completed

    1 trial

  11. Salmeterol/fluticasone propionate or formoterol/budesonide

    GlaxoSmithKline

    Asthma

    approved small molecule completed

    1 trial

  12. Shingrix powder and suspension for suspension for injection Herpes zoster vaccine (recombinant, adjuvanted), Shingrix powder and suspension for suspension for injection Herpes zoster vaccine (recombinant, adjuvanted)

    GlaxoSmithKline

    Herpes Zoster

    approved small molecule active

    1 trial

  13. The Placebo used for the clinical trial is a sterile saline solution (0.9% w/v solution of NaCl in water) supplied in 1.25 mL pre-filled glass syringes., Shingrix suspension for injection in pre filled syringe Herpes zoster vaccine (recombinant, adjuvanted), Shingrix powder and suspension for suspension for injection Herpes zoster vaccine (recombinant, adjuvanted)

    GlaxoSmithKline

    Incident dementia

    approved small molecule active

    1 trial

  14. adefovir dipivoxil

    GlaxoSmithKline

    Hepatitis B, Chronic

    approved small molecule completed

    1 trial

  15. pioglitazone

    GlaxoSmithKline

    Diabetes Mellitus, Type 2

    approved small molecule terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources